{"id":"NCT01785472","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension","officialTitle":"A Multi-center, Randomized, Double-blind, Active-controlled, 8-week Study to Evaluate the Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Patients With Essential Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-04","primaryCompletion":"2014-08","completion":"2014-08","firstPosted":"2013-02-07","resultsPosted":"2015-09-04","lastUpdate":"2016-12-29"},"enrollment":1438,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Essential Hypertension"],"interventions":[{"type":"DRUG","name":"LCZ696","otherNames":[]},{"type":"DRUG","name":"Olmesartan","otherNames":[]},{"type":"DRUG","name":"Placebo of LCZ696","otherNames":[]},{"type":"DRUG","name":"Placebo of Olmesartan","otherNames":[]}],"arms":[{"label":"LCZ696 200 mg","type":"EXPERIMENTAL"},{"label":"LCZ696 400 mg","type":"EXPERIMENTAL"},{"label":"Olmesartan 20 mg","type":"ACTIVE_COMPARATOR"}],"summary":"This study will assess the efficacy and safety of multiple doses of LCZ696 compared to olmesartan in Asian patients with essential hypertension","primaryOutcome":{"measure":"Change From Baseline in Mean Sitting Systolic Blood Pressure (msSBP) Between LCZ696 200 mg Versus Olmesartan 20 mg","timeFrame":"baseline, 8 weeks","effectByArm":[{"arm":"LCZ696 200 mg","deltaMin":-20.48,"sd":0.61},{"arm":"Olmesartan 20 mg","deltaMin":-18.15,"sd":0.61}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":50,"countries":["China","Hong Kong","Philippines","Singapore","South Korea","Taiwan","Thailand"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":478},"commonTop":["HYPERLIPIDAEMIA","HYPERURICAEMIA","UPPER RESPIRATORY TRACT INFECTION","BLOOD GLUCOSE INCREASED","DIZZINESS"]}}